Creavo celebrates 5-year anniversary
By Steve Parker, Chief Executive Officer
This week marks five years since Creavo was formed – and another milestone as we celebrate Creavo entering an exciting and pivotal phase in its journey. We are now in the final stages of commercial preparation to launch our portable magnetocardiography (MCG) device Corsens®.
Corsens® has the potential to address an unmet clinical need in global Emergency Departments as an aid for physicians to rule out Acute Coronary Syndrome in patients presenting to the emergency department (ED) with cardiac related chest pain.
The past five years has seen us build a team of distinguished medical and technical experts. Their significant knowledge and expertise have enabled Creavo to develop a world-class device which has the potential to perform an important function with the emergency clinicians in mind.
The team is underpinned by a medical advisory board comprising of leading cardiologists who understand the need for a more effective and efficient triage system and are committed to the development of Corsens®.
We’ve also been working with leading emergency departments in both the UK and US, who have used our research device Vitalscan in large-scale clinical multi-center studies. The results of the UK study will be published this year and will provide evidence on effectiveness and safety.
The work done by the continuously growing team here at Creavo in the areas of research, clinical studies, marketing activities, Infrastructure, systems and product development have all been key to three successful investment rounds since Creavo’s inception since April 2014.
Chest pain triage is a challenge for Emergency Departments across the world, and our vision for Corsens® is to see it adopted globally to aid clinicians in the accurate rule out of Acute Coronary Syndromes (ACS).
The team at Creavo are incredibly proud of the progress we have made so far and are very excited about taking this success to the next level.